This will be good for at least a run back to 80.
Like Man Meat, Tea Bag, and Oil at the Jack in the Crack, KOOL's dotting their i's and crossing their t's on this done deal.
Wire the cash!
well, I wanted you to explain why you said that it cannot be used in operating room in Europe when the dutch company told is primarily used in operating room in Europe... is also used by the HUG in Switzerland
the market is small, define what small is... in term of money... only in Europe KOOL is looking for more than 200M, so you probably know the market size of US, ASIA and eventually South America...
I think you don't know very well what you are talking about
please give your idea of small market in $$$ so I can check your knowledge. I am expecting a clear answer from you... with fact!! thanks
In the US, Cryoseal is only approved for liver resections and cannot be used for other indications, so it is the only possible use in the US.
In Europe, it can be used for all applications, but is has to be produced by blood banks. It is not a pharmaceutical product like Baxter's Tissucol, which can be sold directly to the OR.
Although fibrin sealant is a blood product, it is commonly not produced by blood banks and therefore, it needs to be registered in every single country.
Baxter has multiple indications in the US and in the rest of the world. There is a market for fibrin sealant, but the market for Cryoseal is so small because of what I just explained above.
If I remember correctly, liver surgery was the application that KOOL sought FDA approval for. Perhaps they were thinking that an expansion of approvals would be easy after that. After the initial hype KOOL got really quiet on it. There was some reason that they felt it not worth pursuing.
Additionally, fibrin sealants are used more and more everyday for an expanding type of wounds.
Where does this liver stuff come from? You seem to be trying to get people to think that is the only possible use!
Cryoseal question- Why would you be posting that the product cannot be used in Europe because, among other things, hospitals don't have license to use blood products? That made little sense to me as hospitals use blood products and plasma all day long. Before I could look into it though, blacknwhite posted (with links)and showed that fibrin sealants are used extensively in Europe( per the FTC).
back in 1996: "The United States market for FDA-approved fibrin sealants could be as large as $400 million per year, the Commission said..."
2010 is well over a billion...
Baxter knows... and so does KOOL
No market in US for fibrin sealant? than you should ask yourself why baxter has is hand on it
I am not an expert in fibrin sealant but I think you have to do something better if you want that your lies somehow affect the investor perception of this company